PRESS RELEASE published on 02/17/2023 at 17:00, 3 years 5 months ago Health Canada Authorizes Moderna's Omicron-Targeting Bivalent COVID-19 Vaccine in Children & Adolescents (6-17 Years)
PRESS RELEASE published on 02/16/2023 at 22:05, 3 years 5 months ago Moderna Announces Interim Phase 3 Safety and Immunogenicity Results for mRNA-1010, a Seasonal Influenza Vaccine Candidate
PRESS RELEASE published on 02/02/2023 at 13:00, 3 years 6 months ago Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023
PRESS RELEASE published on 01/30/2023 at 13:15, 3 years 6 months ago Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate
PRESS RELEASE published on 01/17/2023 at 22:05, 3 years 6 months ago Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older Adults
PRESS RELEASE published on 01/09/2023 at 13:00, 3 years 7 months ago Moderna Announces Advances Across mRNA Pipeline and Provides Business Update
PRESS RELEASE published on 01/05/2023 at 22:05, 3 years 7 months ago Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Published on 08/11/2026 at 14:30, 1 hour 26 minutes ago ACCESS Newswire Reports Second Quarter 2026 Results
Published on 08/11/2026 at 14:30, 1 hour 26 minutes ago AIAI Holdings' Constellation Network Launches Dôr Retail Intelligence: Transformational AI-Powered Retail Intelligence
Published on 08/11/2026 at 14:00, 1 hour 56 minutes ago First Canadian Graphite Signs Agreement with Groupe Nipi, in Collaboration with BBA, for its Preliminary Environmental Study at Lac Guéret Sud
Published on 08/11/2026 at 14:00, 1 hour 56 minutes ago First Canadian Graphite conclut une entente avec le Groupe Nipi en collaboration avec la firme BBA pour une étude environnementale préliminaire au Lac Guéret Sud
Published on 08/11/2026 at 13:30, 2 hours 26 minutes ago Nextech3D.ai CEO Evan Gappelberg Purchases 250,000 Shares in Open Market
Published on 08/11/2026 at 15:46, 10 minutes ago GANÉ Value Event Fund: Target cash distribution of 4 per cent per year achieved
Published on 08/10/2026 at 18:00, 21 hours 56 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 21 hours 56 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 22 hours 11 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 1 day 4 hours ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026